vincamine has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, C; Li, L; Liu, J; Su, Y | 1 |
| Braun, D; Feinstein, DL | 1 |
| Grummich, KW; Mandybur, TI; Means, ED; Ritschel, WA | 1 |
| Casset-Senon, D; Delbarre, B; Delbarre, G | 1 |
| Cahn, J | 1 |
| D'Agata, V; Drago, F; Grassi, M; Lauria, N; Spadaro, F; Valerio, C | 1 |
| Blavet, N; Clostre, F; Spinnewyn, B | 1 |
| Grummich, KW; Mandybur, TI; Means, ED; Ritschel, WA; Vorhees, CV | 1 |
9 other study(ies) available for vincamine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Efficacy of Vincamine treatment in a rat model of anterior ischemic optic neuropathy.
Topics: Animals; Disease Models, Animal; Optic Neuropathy, Ischemic; Rats; Retinal Ganglion Cells; Signal Transduction; Vincamine | 2021 |
The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.
Topics: Adrenergic Neurons; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Disease Progression; Hippocampus; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Degeneration; Neurons; Neuroprotective Agents; Norepinephrine; Phosphodiesterase I; Vincamine | 2019 |
The effects of vincamine on experimental cerebral infarction in Mongolian gerbils: a pilot study.
Topics: Animals; Brain; Carotid Arteries; Cerebral Infarction; Disease Models, Animal; Gerbillinae; Male; Vinca Alkaloids; Vincamine | 1984 |
[The use of the Mongolian gerbil as a model for cerebrovascular involvement].
Topics: 5-Hydroxytryptophan; Animals; Brain Ischemia; Circle of Willis; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Rodent Diseases; Vincamine | 1980 |
[Pathopharmacologic models of cerebral disorders].
Topics: Aging; Animals; Arteriosclerosis; Cerebrovascular Circulation; Dementia; Dihydroergotoxine; Disease Models, Animal; Dogs; Energy Metabolism; Glucose; Humans; Hypoxia, Brain; Memory; Neurons; Partial Pressure; Rabbits; Vincamine | 1979 |
Effects of vinburnine on experimental models of learning and memory impairments.
Topics: Amnesia, Retrograde; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Learning Disabilities; Male; Mice; Nicergoline; Pentylenetetrazole; Rats; Rats, Inbred Strains; Scopolamine; Seizures; Vinca Alkaloids; Vincamine | 1990 |
[Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils].
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Drug Evaluation, Preclinical; Gerbillinae; Mitochondria; Nicergoline; Oxygen Consumption; Plant Extracts; Plants, Medicinal; Trees; Vincamine | 1986 |
Experimental cerebral infarction in Mongolian gerbils: effects of vincamine on lesion size, survival and behavior.
Topics: Animals; Body Weight; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking; Eating; Gerbillinae; Male; Motor Activity; Vinca Alkaloids; Vincamine | 1985 |